# Dauch Corp: financial statements, quarterly

DCH · NYSE · CIK 1062231 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dch.md) · [Financials](/companies/dch/financials.md) · [Filings](/companies/dch/filings.md) · [Insiders](/companies/dch/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dch/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,552](/filings/0001062231-24-000094.md) | [1,463 d](/filings/0001062231-26-000020.md) | [1,607](/filings/0001062231-25-000050.md) | [1,632](/filings/0001062231-25-000087.md) | [1,505](/filings/0001062231-25-000097.md) | [1,381 d](/filings/0001062231-26-000020.md) | [1,411](/filings/0001062231-26-000126.md) | [1,536](/filings/0001062231-26-000139.md) | [1,505](/filings/0001062231-25-000097.md) | [1,384 d](/filings/0001062231-26-000020.md) | [2,379](/filings/0001062231-26-000126.md) | [2,956](/filings/0001062231-26-000139.md) |
| Cost of revenue | $m | [1,421](/filings/0001062231-24-000094.md) | [1,308 d](/filings/0001062231-26-000020.md) | [1,408](/filings/0001062231-25-000050.md) | [1,415](/filings/0001062231-25-000087.md) | [1,334](/filings/0001062231-25-000097.md) | [1,227 d](/filings/0001062231-26-000020.md) | [1,237](/filings/0001062231-26-000126.md) | [1,336](/filings/0001062231-26-000139.md) | [1,316](/filings/0001062231-25-000097.md) | [1,243 d](/filings/0001062231-26-000020.md) | [2,154](/filings/0001062231-26-000126.md) | [2,617](/filings/0001062231-26-000139.md) |
| Gross profit | $m | [131](/filings/0001062231-24-000094.md) | [155 d](/filings/0001062231-26-000020.md) | [199](/filings/0001062231-25-000050.md) | [217](/filings/0001062231-25-000087.md) | [171](/filings/0001062231-25-000097.md) | [154 d](/filings/0001062231-26-000020.md) | [174](/filings/0001062231-26-000126.md) | [201](/filings/0001062231-26-000139.md) | [189](/filings/0001062231-25-000097.md) | [141 d](/filings/0001062231-26-000020.md) | [225](/filings/0001062231-26-000126.md) | [338](/filings/0001062231-26-000139.md) |
| Selling, general and administrative | $m | [81.8](/filings/0001062231-24-000094.md) | [95.7 d](/filings/0001062231-26-000020.md) | [98.3](/filings/0001062231-25-000050.md) | [105](/filings/0001062231-25-000087.md) | [94.6](/filings/0001062231-25-000097.md) | [89.0 d](/filings/0001062231-26-000020.md) | [90.9](/filings/0001062231-26-000126.md) | [101](/filings/0001062231-26-000139.md) | [98.8](/filings/0001062231-25-000097.md) | [98.5 d](/filings/0001062231-26-000020.md) | [137](/filings/0001062231-26-000126.md) | [167](/filings/0001062231-26-000139.md) |
| Operating income | $m | [23.9](/filings/0001062231-24-000094.md) | [28.8 d](/filings/0001062231-26-000020.md) | [77.0](/filings/0001062231-25-000050.md) | [86.5](/filings/0001062231-25-000087.md) | [41.7](/filings/0001062231-25-000097.md) | [36.2 d](/filings/0001062231-26-000020.md) | [42.7](/filings/0001062231-26-000126.md) | [55.0](/filings/0001062231-26-000139.md) | [48.4](/filings/0001062231-25-000097.md) | [(33.8) d](/filings/0001062231-26-000020.md) | [(33.7)](/filings/0001062231-26-000126.md) | [99.7](/filings/0001062231-26-000139.md) |
| Interest expense | $m | [50.8](/filings/0001062231-24-000094.md) | [50.2 d](/filings/0001062231-26-000020.md) | [49.0](/filings/0001062231-25-000050.md) | [47.9](/filings/0001062231-25-000087.md) | [45.2](/filings/0001062231-25-000097.md) | [43.9 d](/filings/0001062231-26-000020.md) | [42.9](/filings/0001062231-26-000126.md) | [43.1](/filings/0001062231-26-000139.md) | [42.7](/filings/0001062231-25-000097.md) | [72.4 d](/filings/0001062231-26-000020.md) | [89.6](/filings/0001062231-26-000126.md) | [89.8](/filings/0001062231-26-000139.md) |
| Income tax | $m | [(2.0)](/filings/0001062231-24-000094.md) | [5.8 d](/filings/0001062231-26-000020.md) | [15.9](/filings/0001062231-25-000050.md) | [17.2](/filings/0001062231-25-000087.md) | [(12.1)](/filings/0001062231-25-000097.md) | [6.8 d](/filings/0001062231-26-000020.md) | [14.0](/filings/0001062231-26-000126.md) | [28.1](/filings/0001062231-26-000139.md) | [(10.9)](/filings/0001062231-25-000097.md) | [(10.0) d](/filings/0001062231-26-000020.md) | [(19.6)](/filings/0001062231-26-000126.md) | [16.1](/filings/0001062231-26-000139.md) |
| Net income | $m | [(17.4)](/filings/0001062231-24-000094.md) | [(19.1) d](/filings/0001062231-26-000020.md) | [20.5](/filings/0001062231-25-000050.md) | [18.2](/filings/0001062231-25-000087.md) | [10.0](/filings/0001062231-25-000097.md) | [(13.7) d](/filings/0001062231-26-000020.md) | [7.1](/filings/0001062231-26-000126.md) | [39.3](/filings/0001062231-26-000139.md) | [9.2](/filings/0001062231-25-000097.md) | [(75.3) d](/filings/0001062231-26-000020.md) | [(100)](/filings/0001062231-26-000126.md) | [1.0](/filings/0001062231-26-000139.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001062231-24-000094.md) | not reported | [0.17](/filings/0001062231-25-000050.md) | [0.15](/filings/0001062231-25-000087.md) | [0.08](/filings/0001062231-25-000097.md) | not reported | [0.06](/filings/0001062231-26-000126.md) | [0.32](/filings/0001062231-26-000139.md) | [0.07](/filings/0001062231-25-000097.md) | not reported | [(0.52)](/filings/0001062231-26-000126.md) | [0.00](/filings/0001062231-26-000139.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0001062231-24-000094.md) | not reported | [0.17](/filings/0001062231-25-000050.md) | [0.15](/filings/0001062231-25-000087.md) | [0.08](/filings/0001062231-25-000097.md) | not reported | [0.06](/filings/0001062231-26-000126.md) | [0.32](/filings/0001062231-26-000139.md) | [0.07](/filings/0001062231-25-000097.md) | not reported | [(0.52)](/filings/0001062231-26-000126.md) | [0.00](/filings/0001062231-26-000139.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0001062231-23-000064.md) | [0.5](/filings/0001062231-25-000008.md) | [0.5](/filings/0001062231-24-000054.md) | [0.5](/filings/0001062231-24-000084.md) | [0.5](/filings/0001062231-24-000094.md) | [0.6](/filings/0001062231-26-000020.md) | [0.5](/filings/0001062231-25-000050.md) | [0.6](/filings/0001062231-25-000087.md) | [0.7](/filings/0001062231-25-000097.md) | [0.7](/filings/0001062231-26-000139.md) | [1.0](/filings/0001062231-26-000126.md) | [0.9](/filings/0001062231-26-000139.md) |
| Current assets | $bn | [2.1](/filings/0001062231-23-000064.md) | [2.0](/filings/0001062231-25-000008.md) | [2.1](/filings/0001062231-24-000054.md) | [2.1](/filings/0001062231-24-000084.md) | [2.1](/filings/0001062231-24-000094.md) | [1.9](/filings/0001062231-26-000020.md) | [2.0](/filings/0001062231-25-000050.md) | [2.2](/filings/0001062231-25-000087.md) | [2.3](/filings/0001062231-25-000097.md) | [3.6](/filings/0001062231-26-000139.md) | [3.9](/filings/0001062231-26-000126.md) | [3.7](/filings/0001062231-26-000139.md) |
| Total assets | $bn | [5.5](/filings/0001062231-23-000064.md) | [5.4](/filings/0001062231-26-000020.md) | [5.4](/filings/0001062231-25-000050.md) | [5.3](/filings/0001062231-25-000087.md) | [5.3](/filings/0001062231-25-000097.md) | [5.1](/filings/0001062231-26-000020.md) | [5.1](/filings/0001062231-26-000126.md) | [5.3](/filings/0001062231-26-000139.md) | [5.3](/filings/0001062231-25-000097.md) | [6.7](/filings/0001062231-26-000139.md) | [11.3](/filings/0001062231-26-000126.md) | [11.1](/filings/0001062231-26-000139.md) |
| Current liabilities | $bn | [1.2](/filings/0001062231-23-000064.md) | [1.2](/filings/0001062231-25-000008.md) | [1.2](/filings/0001062231-24-000054.md) | [1.3](/filings/0001062231-24-000084.md) | [1.3](/filings/0001062231-24-000094.md) | [1.2](/filings/0001062231-26-000020.md) | [1.2](/filings/0001062231-25-000050.md) | [1.2](/filings/0001062231-25-000087.md) | [1.3](/filings/0001062231-25-000097.md) | [1.2](/filings/0001062231-26-000139.md) | [2.8](/filings/0001062231-26-000126.md) | [2.7](/filings/0001062231-26-000139.md) |
| Total liabilities | $bn | [4.9](/filings/0001062231-23-000064.md) | [4.8](/filings/0001062231-25-000008.md) | [4.7](/filings/0001062231-24-000054.md) | [4.7](/filings/0001062231-24-000084.md) | [4.7](/filings/0001062231-24-000094.md) | [4.5](/filings/0001062231-26-000020.md) | [4.5](/filings/0001062231-25-000050.md) | [4.6](/filings/0001062231-25-000087.md) | [4.6](/filings/0001062231-25-000097.md) | [6.0](/filings/0001062231-26-000139.md) | [9.8](/filings/0001062231-26-000126.md) | [9.5](/filings/0001062231-26-000139.md) |
| Long-term debt | $bn | [2.9](/filings/0001062231-23-000064.md) | [2.8](/filings/0001062231-25-000008.md) | [2.8](/filings/0001062231-24-000054.md) | [2.7](/filings/0001062231-24-000084.md) | [2.7](/filings/0001062231-24-000094.md) | [2.6](/filings/0001062231-26-000020.md) | [2.6](/filings/0001062231-25-000050.md) | [2.6](/filings/0001062231-25-000087.md) | [2.6](/filings/0001062231-25-000097.md) | [4.1](/filings/0001062231-26-000139.md) | [5.3](/filings/0001062231-26-000126.md) | [5.1](/filings/0001062231-26-000139.md) |
| Current portion of debt | $bn | [0.0](/filings/0001062231-23-000064.md) | [0.0](/filings/0001062231-25-000008.md) | [0.0](/filings/0001062231-24-000054.md) | [0.0](/filings/0001062231-24-000084.md) | [0.0](/filings/0001062231-24-000094.md) | [0.0](/filings/0001062231-26-000020.md) | [0.0](/filings/0001062231-25-000050.md) | [0.0](/filings/0001062231-25-000087.md) | [0.0](/filings/0001062231-25-000097.md) | [0.0](/filings/0001062231-26-000139.md) | [0.0](/filings/0001062231-26-000126.md) | [0.0](/filings/0001062231-26-000139.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [0.6](/filings/0001062231-23-000064.md) | [0.6](/filings/0001062231-25-000008.md) | [0.6](/filings/0001062231-24-000054.md) | [0.6](/filings/0001062231-24-000084.md) | [0.6](/filings/0001062231-24-000094.md) | [0.6](/filings/0001062231-26-000020.md) | [0.6](/filings/0001062231-25-000050.md) | [0.7](/filings/0001062231-25-000087.md) | [0.7](/filings/0001062231-25-000097.md) | [0.6](/filings/0001062231-26-000139.md) | [1.5](/filings/0001062231-26-000126.md) | [1.5](/filings/0001062231-26-000139.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [178 d](/filings/0001062231-24-000094.md) | [52.9 d](/filings/0001062231-26-000020.md) | [17.8](/filings/0001062231-25-000050.md) | [143 d](/filings/0001062231-25-000087.md) | [144 d](/filings/0001062231-25-000097.md) | [151 d](/filings/0001062231-26-000020.md) | [55.9](/filings/0001062231-26-000126.md) | [91.9 d](/filings/0001062231-26-000139.md) | [143 d](/filings/0001062231-25-000097.md) | [121 d](/filings/0001062231-26-000020.md) | [(64.4)](/filings/0001062231-26-000126.md) | [108 d](/filings/0001062231-26-000139.md) |
| Capital expenditure | $m | [47.9 d](/filings/0001062231-24-000094.md) | [56.0 d](/filings/0001062231-26-000020.md) | [48.0](/filings/0001062231-25-000050.md) | [48.8 d](/filings/0001062231-25-000087.md) | [73.2 d](/filings/0001062231-25-000097.md) | [78.0 d](/filings/0001062231-26-000020.md) | [69.3](/filings/0001062231-26-000126.md) | [57.3 d](/filings/0001062231-26-000139.md) | [64.1 d](/filings/0001062231-25-000097.md) | [65.8 d](/filings/0001062231-26-000020.md) | [104](/filings/0001062231-26-000126.md) | [98.3 d](/filings/0001062231-26-000139.md) |
| Share repurchases | $m | [0.0 d](/filings/0001062231-24-000094.md) | [0.0 d](/filings/0001062231-26-000020.md) | [2.7](/filings/0001062231-25-000050.md) | [0.1 d](/filings/0001062231-25-000087.md) | [0.0 d](/filings/0001062231-25-000097.md) | [0.0 d](/filings/0001062231-26-000020.md) | [2.7](/filings/0001062231-26-000126.md) | [0.0 d](/filings/0001062231-26-000139.md) | [0.0 d](/filings/0001062231-25-000097.md) | [0.1 d](/filings/0001062231-26-000020.md) | [6.2](/filings/0001062231-26-000126.md) | [2.0 d](/filings/0001062231-26-000139.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [116](/filings/0001062231-23-000064.md) | [115](/filings/0001062231-24-000054.md) | [117](/filings/0001062231-24-000084.md) | [117](/filings/0001062231-24-000094.md) | [117](/filings/0001062231-25-000050.md) | [118](/filings/0001062231-25-000087.md) | [118](/filings/0001062231-25-000097.md) | [118](/filings/0001062231-26-000126.md) | [119](/filings/0001062231-26-000139.md) | [119](/filings/0001062231-25-000097.md) | [193](/filings/0001062231-26-000126.md) | [238](/filings/0001062231-26-000139.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 237,604,602 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001062231-26-000139.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.